Citadel Advisors’s Surgery Partners SGRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.79M | Sell |
401,551
-188,270
| -32% | -$2.7M | ﹤0.01% | 4411 |
|
|
2025
Q4 | $9.11M | Buy |
589,821
+555,261
| +1,607% | +$10.2M | ﹤0.01% | 3389 |
|
|
2025
Q3 | $748K | Sell |
34,560
-214,408
| -86% | -$4.78M | ﹤0.01% | 8186 |
|
|
2025
Q2 | $5.53M | Sell |
248,968
-104,017
| -29% | -$2.31M | ﹤0.01% | 3929 |
|
|
2025
Q1 | $8.38M | Buy |
352,985
+299,621
| +561% | +$7.09M | ﹤0.01% | 3090 |
|
|
2024
Q4 | $1.13M | Buy |
53,364
+44,036
| +472% | +$1.16M | ﹤0.01% | 6759 |
|
|
2024
Q3 | $301K | Sell |
9,328
-118,960
| -93% | -$3.51M | ﹤0.01% | 9330 |
|
|
2024
Q2 | $3.05M | Sell |
128,288
-13,468
| -10% | -$346K | ﹤0.01% | 4534 |
|
|
2024
Q1 | $4.23M | Buy |
141,756
+135,885
| +2,315% | +$4.25M | ﹤0.01% | 4203 |
|
|
2023
Q4 | $188K | Sell |
5,871
-17,905
| -75% | -$520K | ﹤0.01% | 10045 |
|
|
2023
Q3 | $695K | Sell |
23,776
-98,534
| -81% | -$3.54M | ﹤0.01% | 7355 |
|
|
2023
Q2 | $5.5M | Sell |
122,310
-149,295
| -55% | -$5.7M | ﹤0.01% | 3508 |
|
|
2023
Q1 | $9.36M | Buy |
271,605
+56,465
| +26% | +$1.83M | ﹤0.01% | 2898 |
|
|
2022
Q4 | $5.99M | Buy |
215,140
+67,980
| +46% | +$1.8M | ﹤0.01% | 3569 |
|
|
2022
Q3 | $3.44M | Buy |
147,160
+90,248
| +159% | +$2.88M | ﹤0.01% | 4532 |
|
|
2022
Q2 | $1.65M | Sell |
56,912
-5,906
| -9% | -$258K | ﹤0.01% | 5949 |
|
|
2022
Q1 | $3.46M | Sell |
62,818
-51,961
| -45% | -$2.57M | ﹤0.01% | 4894 |
|
|
2021
Q4 | $6.13M | Buy |
114,779
+33,788
| +42% | +$1.57M | ﹤0.01% | 3938 |
|
|
2021
Q3 | $3.43M | Buy |
80,991
+22,462
| +38% | +$1.15M | ﹤0.01% | 5074 |
|
|
2021
Q2 | $3.9M | Sell |
58,529
-42,350
| -42% | -$2.3M | ﹤0.01% | 4992 |
|
|
2021
Q1 | $4.46M | Sell |
100,879
-71,820
| -42% | -$2.67M | ﹤0.01% | 4508 |
|
|
2020
Q4 | $5.01M | Buy |
172,699
+120,465
| +231% | +$3M | ﹤0.01% | 3684 |
|
|
2020
Q3 | $1.14M | Sell |
52,234
-13,416
| -20% | -$238K | ﹤0.01% | 5792 |
|
|
2020
Q2 | $760K | Sell |
65,650
-178,130
| -73% | -$1.95M | ﹤0.01% | 6338 |
|
|
2020
Q1 | $1.59M | Sell |
243,780
-163,849
| -40% | -$2.34M | ﹤0.01% | 4519 |
|
|
2019
Q4 | $6.38M | Sell |
407,629
-204,844
| -33% | -$2.32M | ﹤0.01% | 2780 |
|
|
2019
Q3 | $4.52M | Buy |
612,473
+67,525
| +12% | +$483K | ﹤0.01% | 3248 |
|
|
2019
Q2 | $4.44M | Buy |
544,948
+80,775
| +17% | +$805K | ﹤0.01% | 3274 |
|
|
2019
Q1 | $5.24M | Buy |
464,173
+219,096
| +89% | +$2.76M | ﹤0.01% | 2940 |
|
|
2018
Q4 | $2.4M | Buy |
245,077
+129,356
| +112% | +$1.74M | ﹤0.01% | 3866 |
|
|
2018
Q3 | $1.91M | Buy |
115,721
+94,352
| +442% | +$1.51M | ﹤0.01% | 4493 |
|
|
2018
Q2 | $318K | Buy |
+21,369
| New | +$358K | ﹤0.01% | 7114 |
|
|
2017
Q4 | – | Sell |
-12,467
| Closed | -$129K | – | 8398 |
|
|
2017
Q3 | $129K | Buy |
+12,467
| New | +$178K | ﹤0.01% | 6940 |
|
|
2017
Q2 | – | Sell |
-11,397
| Closed | -$222K | – | 8004 |
|
|
2017
Q1 | $222K | Sell |
11,397
-632
| -5% | -$12.3K | ﹤0.01% | 6347 |
|
|
2016
Q4 | $191K | Buy |
+12,029
| New | +$200K | ﹤0.01% | 6338 |
|
|
2016
Q3 | – | Sell |
-21,450
| Closed | -$384K | – | 7708 |
|
|
2016
Q2 | $384K | Buy |
21,450
+2,228
| +12% | +$33.2K | ﹤0.01% | 4858 |
|
|
2016
Q1 | $255K | Buy |
+19,222
| New | +$297K | ﹤0.01% | 5309 |
|
Other funds holding SGRY
BCI
PCM
KSCM
VPM
VCM
Citadel Advisors's SGRY Position: Q1 2026 in Review
Citadel Advisors reduced its Surgery Partners (SGRY) stake by 32% in Q1 2026, selling an estimated $2.7M and leaving 401,551 shares worth $4.79M. The position accounts for ﹤0.01% of the portfolio, ranked #4411.
Citadel Advisors first reported a position in SGRY in Q1 2016 and has held it in 37 quarters since. The position peaked at $9.36M in Q1 2023. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.
- Citadel Advisors held 401,551 shares of Surgery Partners worth $4.79M as of Q1 2026.
- Citadel Advisors sold 188,270 Surgery Partners shares in Q1 2026, an estimated $2.7M.
- Surgery Partners made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4411 holding.
- Citadel Advisors first reported a position in Surgery Partners in Q1 2016 and has held it in 37 quarters since.
- Citadel Advisors's Surgery Partners position peaked at $9.36M in Q1 2023.
- 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.